HHS and the Department of Defense (DoD) recently announced a $1.6 billion agreement with Novavax Inc. to demonstrate commercial-sale manufacturing of the company’s COVID-19 investigational...
HHS recently announced a $628 million task order with Emergent BioSolutions to advance manufacturing capabilities for potential COVID-19 vaccines and therapeutics.
For more coronavirus updates,...
HHS recently announced that it will expand pharmaceutical manufacturing in the US to produce medicines needed during the COVID-19 pandemic and boost capacity for producing finished generic drugs.
For...
AstraZeneca recently announced that it is enhancing its response to the current pandemic and collaborating with multiple countries and organizations to make the University of Oxford’s COVID-19...
The Trump Administration recently released framework and leadership for Operation Warp Speed (OWS), a new program designed to accelerate the development, manufacturing, and distribution of COVID-19...
Office of the Assistant Secretary for Preparedness and Response (ASPR) at HHS recently announced the allocation plan for remdesivir, a COVID-19 treatment for hospitalized patients.
For more...
The Subcommittee on Economic and Consumer Policy recently released a staff memo with preliminary findings that showed significant gaps in the Trump Administration’s handling of serological...
The FDA recently issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, which have been deemed as two of the most promising COVID-19 drugs.
For...
Moderna recently received $483 million from the Biomedical Advanced Research and Development Authority (BARDA) to bolster COVID-19 vaccine development using the company’s mRNA vaccine...
HHS has replaced Rick Bright as the director of the US agency charged with developing potential COVID-19 drugs and vaccines, according to national news sources.
For more coronavirus updates, visit...
Johnson & Johnson has identified a lead COVID-19 vaccine candidate and expects to initiate a Phase I human clinical trial by September 2020 at the latest, according to a recent announcement.
For...
The Department of Health and Human Services (HHS) recently announced support for a Phase 2/3 clinical trial to evaluate a possible COVID-19 treatment for severely ill patients.
For more coronavirus...
Tying drug prices to those in other developed countries may be a useful strategy for lowering US prescription drug spending, but international reference pricing may not be ideal, according to...
Janssen Pharmaceutical Companies will expand its partnership with Department of Health and Human Services (HHS) to accelerate a vaccination discovery for the coronavirus or COVID-19, Johnson &...
